Neuland Labs. Financials Statement

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Sep-2023	Jun-2023	Mar-2023	Dec-2022	Sep-2022
Gross Sales	417.75	362.99	407.07	269.25	293.71
Excise Duty	--	--	--	--	--
Net Sales	417.75	362.99	407.07	269.25	293.71
Other Operating Income	--	--	--	--	--
Other Income	3.05	2.04	8.06	0.93	0.24
Total Income	420.80	365.03	415.14	270.18	293.94
Total Expenditure	280.26	266.07	287.21	215.17	224.41
PBIDT	140.54	98.96	127.92	55.02	69.54
Interest	4.43	2.21	4.29	2.74	3.18
PBDT	136.10	96.75	123.63	52.27	66.36
Depreciation	14.51	13.59	13.47	13.34	13.17
Minority Interest Before NP	--	--	--	--	--
Tax	31.44	20.95	25.36	6.65	14.33
Deferred Tax	0.90	0.33	0.26	1.74	0.40
Reported Profit After Tax	89.25	61.88	84.54	30.55	38.46
Minority Interest After NP	--	--	--	--	--
Net Profit after Minority Interest	89.25	61.88	84.54	30.55	38.46
Extra-ordinary Items	--	--	--	--	--
Adjusted Profit After Extra-ordinary item	89.25	61.88	84.54	30.55	38.46
EPS (Unit Curr.)	69.56	48.23	65.90	23.81	29.97
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	--	--	--	--
Equity	12.90	12.90	12.90	12.90	12.90
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	33.64	27.26	31.43	20.43	23.68
PBDTM(%)	32.58	26.65	30.37	19.41	22.59
PATM(%)	21.36	17.05	20.77	11.35	13.10

QuickLinks for Neuland Laboratories Ltd.